Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000 · see citing works

Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey

Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698 · see citing works

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261 · see citing works

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works

Banting lecture 1988. Role of insulin resistance in human disease.

Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801 · see citing works

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · see citing works

Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients

Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · see citing works

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159 · see citing works

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979 · see citing works

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780 · see citing works

Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623 · see citing works

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex

Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · see citing works

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411 · see citing works

Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease: The Bezafibrate Infarction Prevention (BIP) Study

(2000) · Circulation · doi:10.1161/01.cir.102.1.21 · Cited by 1,273 · see citing works

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity

Fujioka, S., Matsuzawa, Y., Tokunaga, K., & Tarui, S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90063-1 · Cited by 1,205 · see citing works

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.148 · Cited by 1,165 · see citing works

Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels: Subgroup Analyses in the Cholesterol And Recurrent Events (CARE) Trial

Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986 · see citing works

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

Steiner, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04209-4 · Cited by 845 · see citing works

Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)

(1998) · Circulation · doi:10.1161/01.cir.97.15.1440 · Cited by 791 · see citing works

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

Steiner, G. A. (2001) · Cited by 732 · see citing works

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

Miyazaki, Y., Mahankali, A., Matsuda, M., Mahankali, S., Hardies, J., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8567 · Cited by 726 · see citing works

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Sniderman, A. D., Shapiro, S., Marpole, D. G. F., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 632 · see citing works

Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography

Enzi, G., Gasparo, M., Biondetti, P., Fiore, D., Semisa, M., & Zurlo, F. (1986) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/44.6.739 · Cited by 547 · see citing works

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90129-5 · Cited by 525 · see citing works

Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography.

Ashwell, M., Cole, T. J., & Dixon, A. K. (1985) · BMJ · doi:10.1136/bmj.290.6483.1692 · Cited by 402 · see citing works

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.

McNamara, J. R., Campos, H., Ordovás, J. M., Peterson, J., Wilson, P. W. F., & Schaefer, E. J. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.5.483 · Cited by 383 · see citing works

Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus

Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 329 · see citing works

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men

Tchernof, A., Lamarche, B., Prud'homme, D., Nadeau, A., Moorjani, S., Labrie, F., Lupien, P. J., & Després, J.-P. (1996) · Diabetes Care · doi:10.2337/diacare.19.6.629 · Cited by 323 · see citing works

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.

Kelly, I. E., Han, T. S., Walsh, K., & Lean, M. E. J. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.288 · Cited by 314 · see citing works

The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.

Nieves, D. J., Cnop, M., Retzlaff, B., Walden, C. E., Brunzell, J. D., Knopp, R. H., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.1.172 · Cited by 281 · see citing works

Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression: Hepatic Lipase–Mediated Changes in LDL Density

Zambon, A., Hokanson, J. E., Brown, B. G., & Brunzell, J. D. (1999) · Circulation · doi:10.1161/01.cir.99.15.1959 · Cited by 263 · see citing works

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study.

Austin, M. A., McKnight, B., Edwards, K. L., Bradley, C. M., McNeely, M. J., Psaty, B. M., Brunzell, J. D., & Motulsky, A. G. (2000) · Circulation · doi:10.1161/01.cir.101.24.2777 · Cited by 255 · see citing works

Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat.

Després, J., Moorjani, S., Ferland, M., Tremblay, A., Lupien, P. J., Nadeau, A., Pinault, S., Thériault, G., & Bouchard, C. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.2.203 · Cited by 254 · see citing works

Effect of hepatic lipase on LDL in normal men and those with coronary artery disease.

Zambon, A., Austin, M. A., Brown, B. G., Hokanson, J. E., & Brunzell, J. D. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.147 · Cited by 249 · see citing works

Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions

Packard, C. J., Demant, T., Stewart, J., Bedford, D. K., CASLAKE, M. J., Schwertfeger, G., Bedynek, A., Shepherd, J., & Seidel, D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32065-4 · Cited by 240 · see citing works

Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus

Freed, M. I., Ratner, R. E., Marcovina, S. M., Kreider, M. S., Biswas, N., Cohen, B. R., & Brunzell, J. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02659-0 · Cited by 238 · see citing works

Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.

Austin, M. A., King, M., VRANIZAN, K. M., Newman, B. M., & Krauss, R. M. (1988) · PubMed · Cited by 234 · see citing works

LDL particle size distribution. Results from the Framingham Offspring Study.

Campos, H., Blijlevens, E., McNamara, J., Ordovás, J. M., Posner, B. M., Wilson, P. W., Castelli, W. P., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.12.1410 · Cited by 228 · see citing works

Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients

Carey, D., Cowin, G., Galloway, G. J., Jones, N. P., Richards, J. C., Biswas, N., & Doddrell, D. M. (2002) · Obesity Research · doi:10.1038/oby.2002.137 · Cited by 210 · see citing works

Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus

Taskinen, M. (1992) · Diabetes · doi:10.2337/diab.41.2.s12 · Cited by 174 · see citing works

Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men

Purnell, J. Q. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.977 · Cited by 161 · see citing works

Dyslipidemia of the metabolic syndrome

Ruotolo, G., & Howard, B. V. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0113-6 · Cited by 155 · see citing works

Abnormal Body Fat Distribution Detected by Computed Tomography in Diabetic Men

Shuman, W. P., Morris, L., Leonetti, D. L., WAHL, P. W., Moceri, V. M., Moss, A. A., & Fujimoto, W. Y. (1986) · Investigative Radiology · doi:10.1097/00004424-198606000-00007 · Cited by 148 · see citing works

Dyslipidemia of central obesity and insulin resistance.

Brunzell, J. D., & Hokanson, J. E. (1999) · PubMed · Cited by 135 · see citing works

The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity1

Carr, M. C., Hokanson, J. E., Zambon, A., Deeb, S. S., Barrett, P. H. R., Purnell, J. Q., & Brunzell, J. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7586 · Cited by 120 · see citing works

Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia

McKenney, J. M., McCormick, L. S., Schaefer, E. J., Black, D. M., & Watkins, M. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01639-3 · Cited by 120 · see citing works

Common Hepatic Lipase Gene Promoter Variant Determines Clinical Response to Intensive Lipid-Lowering Treatment

Zambon, A., Deeb, S. S., Brown, B. G., Hokanson, J. E., & Brunzell, J. D. (2001) · Circulation · doi:10.1161/01.cir.103.6.792 · Cited by 114 · see citing works

The visceral adiposity syndrome in Japanese-American men.

Fujimoto, W., Abbate, S. L., Kahn, S. E., Hokansno, J. E., & Brunzell, J. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00076.x · Cited by 111 · see citing works

The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Yale, J., Valiquett, T. R., Ghazzi, M. N., Owens-Grillo, J. K., Whitcomb, R. W., Foyt, H. L., & for the Troglitazone Triple-Therapy Study Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_1-200105010-00010 · Cited by 102 · see citing works

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation—double-blind placebo-controlled trial

Nakamura, T., Funahashi, T., Yamashita, S., Nishida, M., Nishida, Y., Takahashi, M., Hotta, K., Kuriyama, H., Kihara, S., Ohuchi, N., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00319-9 · Cited by 101 · see citing works

Obesity: Mechanisms and Clinical Management

Eckel, R. H. (2003) · Cited by 66 · see citing works

Features of Syndrome X in First-Degree Relatives of NIDDM Patients

Stewart, M. W., Humphriss, D. B., Berrish, T. S., Barriocanal, L. A., Trajano, L. R., Alberti, K. G. M. M., & WALKER, M. C. (1995) · Diabetes Care · doi:10.2337/diacare.18.7.1020 · Cited by 65 · see citing works

New developments in the use of niacin for treatment of hyperlipidemia

Crouse, J. R. (1996) · Coronary Artery Disease · doi:10.1097/00019501-199604000-00009 · Cited by 62 · see citing works

Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study

McNeely, M. J., Edwards, K. L., Marcovina, S. M., Brunzell, J. D., Motulsky, A. G., & Austin, M. A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00528-7 · Cited by 54 · see citing works

Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women.

Pouliot, M. C., Després, J., Nadeau, A., Tremblay, A., Moorjani, S., Lupien, P. J., Thériault, G., & Bouchard, C. (1990) · PubMed · Cited by 42 · see citing works

Hepatic Lipase as a Focal Point for the Development and Treatment of Coronary Artery Disease

Zambon, A., Brown, B. G., Deeb, S. S., & Brunzell, J. D. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34107 · Cited by 29 · see citing works

Multiple Risk Factors in Cardiovascular Disease

Achari, A. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0039-7 · Cited by 25 · see citing works

Relationship of absence or presence of a family history of diabetes to body weight and body fat distribution in type 2 diabetes.

Fujimoto, W. Y., Leonetti, D. L., Newell‐Morris, L. L., Shuman, W. P., & WAHL, P. W. (1991) · PubMed · Cited by 24 · see citing works

Multiple risk factors in cardiovascular disease

Licata, A. A. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90076-q · Cited by 4 · see citing works

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · see citing works

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works

Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.

Havel, P. J. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00132.x · Cited by 607 · see citing works

Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity

Hansel, B., Giral, P., Nobécourt, E., Chantepie, S., Bruckert, É., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 476 · see citing works

The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus

Ginsberg, H. N., & MacCallum, P. R. (2009) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00044.x · Cited by 331 · see citing works

Complications and challenges associated with polycystic ovary syndrome: current perspectives

Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287 · see citing works

Can we identify metabolically healthy but obese individuals (MHO)?

Karelis, A. D., Brochu, M., & RABASA-LHORET, R. P. R. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70156-8 · Cited by 269 · see citing works

Coffee consumption and human health - beneficial or detrimental? - Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus

Ranheim, T., & Halvorsen, B. L. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400109 · Cited by 251 · see citing works

The metabolic syndrome and cardiovascular disease

Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 231 · see citing works

Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents

Baass, A. W., Dubuc, G., Tremblay, M., DELVIN, E. E., O’Loughlin, J. L., Levy, E. H., Davignon, J., & Lambert, M. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.126987 · Cited by 207 · see citing works

A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study

Valkenburg, O., Steegers‐Theunissen, R. P. M., Smedts, H. P. M., Dallinga‐Thie, G. M., Fauser, B. C. J. M., Westerveld, E. H., & Laven, J. S. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1756 · Cited by 201 · see citing works

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

Corona, G., Mannucci, E., Petrone, L., Ricca, V, Balercia, G., Mansani, R., Chiarini, V, Giommi, R., Forti, G., & Maggi, M. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901391 · Cited by 189 · see citing works

Dyslipidemia in women with polycystic ovary syndrome

Kim, J., & Choi, Y. M. (2013) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2013.56.3.137 · Cited by 190 · see citing works

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor

Tenenbaum, A., Klempfner, R., & Fisman, E. Z. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0159-y · Cited by 188 · see citing works

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models

Chen, Y., Hu, Y., Lin, M., Jenkins, A. J., KEECH, A. C., Mott, R., Lyons, T. J., & Ma, J. (2012) · Diabetes · doi:10.2337/db11-0413 · Cited by 183 · see citing works

Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Kalofoutis, C., Piperi, C., Kalofoutis, A., Harris, F., Phoenix, D. A., & Singh, J. (2007) · PubMed Central · Cited by 149 · see citing works

Obesity, hypertension and insulin resistance

Sharma, A. M., & Chetty, V. T. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0175-1 · Cited by 148 · see citing works

Adipose tissue in obesity and obstructive sleep apnoea

Bonsignore, M. R., McNicholas, W. T., Montserrat, J. M., & Eckel, J. (2011) · European Respiratory Journal · doi:10.1183/09031936.00047010 · Cited by 138 · see citing works

Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome

Fortuño, A., San José, G., Moreno, M. U., Beloqui, O., Díez, J., & Zalba, G. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0751 · Cited by 128 · see citing works

Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome

Orio, F., Muscogiuri, G., Nese, C., Palomba, S., Savastano, S., Tafuri, D., Colarieti, G., La Sala, G., Colao, A., & Yildiz, B. O. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.08.026 · Cited by 126 · see citing works

Herbal or Natural Medicines as Modulators of Peroxisome Proliferator‐Activated Receptors and Related Nuclear Receptors for Therapy of Metabolic Syndrome

Huang, T. H.-W., Kota, B. P., Razmovski, V., & Roufogalis, B. D. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960102.x · Cited by 121 · see citing works

Insulin Sensitivity is Impaired in Patients with Migraine

Rainero, I., Limone, P. P., Ferrero, M., Valfrè, W., Pellissetto, C., Rubino, E., Gentile, S., Giudice, R. L., & Pinessi, L. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00928.x · Cited by 116 · see citing works

Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles

Gazi, I. F., Tsimihodimos, V., Tselepis, A. D., Elisaf, M., & Mikhailidis, D. P. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.1.53 · Cited by 98 · see citing works

Beneficial Effects of Pomegranate on Lipid Metabolism in Metabolic Disorders

Hou, C., Zhang, W., Li, J., Du, L., Lv, O., Zhao, S., & Li, J. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800773 · Cited by 97 · see citing works

Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight

Chakraborty, S., Verma, A., Garg, R., Singh, J., & Verma, H. (2023) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514231220780 · Cited by 116 · see citing works

The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial

de Oliveira, A. M., Rondó, P. H. D. C., Luzia, L. A., D’Abronzo, F. H., & Illison, V. K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.010 · Cited by 90 · see citing works

Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy

Huang, E.-J., Kuo, W., Chen, Y.-J., Chen, T.-H., Chang, M.-H., Lu, M., Tzang, B., Hsu, H.-H., Huang, C., & Lee, S. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.025 · Cited by 83 · see citing works

Long-Term Follow-up of the Metabolic Profiles in Obese Patients With Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass

Kim, S., & Richards, W. O. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181d9769b · Cited by 76 · see citing works

Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study

Palomba, S., Falbo, A., Chiossi, G., Muscogiuri, G., Fornaciari, E., Orio, F., Tolino, A., Colao, A., La Sala, G. B., & Zullo, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.005 · Cited by 69 · see citing works

The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors

Perrone, F., Minari, R., Bersanelli, M., Bordi, P., Tiseo, M., Favari, E., Sabato, R., & Buti, S. (2020) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000321 · Cited by 68 · see citing works

Geraniol, Alone and in Combination with Pioglitazone, Ameliorates Fructose-Induced Metabolic Syndrome in Rats via the Modulation of Both Inflammatory and Oxidative Stress Status

Ibrahim, S. M., El-Denshary, E. S., & Abdallah, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117516 · Cited by 62 · see citing works

Obesity and type 2 diabetes

Yaturu, S. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.14012 · Cited by 59 · see citing works

Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese

Niu, N., Zhu, X., Liu, Y., Du, T., Wang, X., Chen, D., Sun, B., Gu, H. F., & Liu, Y. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.641 · Cited by 55 · see citing works

Reduced Apolipoprotein Glycosylation in Patients with the Metabolic Syndrome

Savinova, O. V., Fillaus, K., Jing, L., Harris, W. S., & Shearer, G. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104833 · Cited by 53 · see citing works

Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome

Rizos, E. C., Tambaki, A. P., Gazi, I. F., Tselepis, A. D., & Elisaf, M. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.10.021 · Cited by 50 · see citing works

Analysis of Quantitative Lipid Traits in the Genetics of NIDDM (GENNID) Study

Malhotra, A., & DiStefano, J. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.3007 · Cited by 46 · see citing works

Greenselect Phytosome for Borderline Metabolic Syndrome

Belcaro, G., Ledda, A. G., Hu, S., Cesarone, M. R., Feragalli, B., & Dugall, M. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/869061 · Cited by 45 · see citing works

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes

Betteridge, D. J., & Gibson, M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02095.x · Cited by 45 · see citing works

Pathogenesis of Extraarticular Manifestations in Rheumatoid Arthritis—A Comprehensive Review

Mitrović, J., Hrkač, S., Tečer, J., Golob, M., Posavec, A. L., Mitrović, H. K., & Grgurević, L. (2023) · Biomedicines · doi:10.3390/biomedicines11051262 · Cited by 44 · see citing works

Macrovascular Effects and Safety Issues of Therapies for Type 2 Diabetes

Plutzky, J. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.014 · Cited by 44 · see citing works

Hyperinsulinaemia in migraineurs is associated with nitric oxide stress

Gruber, H.-J., Bernecker, C., Pailer, S., Fauler, G., Horejsi, R., Möller, R., Lechner, A., Fazekas, F., & Truschnig-Wilders, M. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.02012.x · Cited by 44 · see citing works

Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis

Paniagua, R., Orihuela, O., Ventura, M.-D.-J., ávila-Díaz, M., Cisneros, A., Vicenté-Martı́nez, M., Furlong, M.-D.-C., García–González, Z., Villanueva, D., Prado-Uribe, M. D. C., et al. (2008) · Kidney International · doi:10.1038/sj.ki.5002613 · Cited by 43 · see citing works

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

HANSEN, B. C., Tigno, X. T., Benardeau, A. M., Meyer, M., ŠEBÖKOVÁ, E., & Mizrahi, J. L. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-7 · Cited by 42 · see citing works

Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 −455T>C polymorphisms on the susceptibility to diabetic nephropathy

Ng, M. C. Y., Baum, L., So, W. C., Lam, V., Wang, Y., Poon, E., Tomlinson, B., Cheng, S., Lindpaintner, K., & Chan, J. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00628.x · Cited by 40 · see citing works

Relación entre el cociente triglicéridos/cHDL, índices de resistencia a la insulina y factores de riesgo cardiometabólico en mujeres con síndrome del ovario poliquístico

Barrios, M. R., Arata-Bellabarba, G., Valeri, L., & Velázquez-Maldonado, E. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)70553-4 · Cited by 34 · see citing works

Clinical significance of the physicochemical properties of LDL in type 2 diabetes

Scheffer, P. G., Teerlink, T., & Heine, R. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1736-0 · Cited by 34 · see citing works

Diabetes and cardiovascular risk markers

Erdmann, E. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x36459 · Cited by 32 · see citing works

Insight into the Role of LCAT from Mouse Models

Ng, D. S. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000045102.70521.af · Cited by 33 · see citing works

Anti-Müllerian Hormone as a Diagnostic Marker in Egyptian Infertile Polycystic Ovary Syndrome Females: Correlations with Vitamin D, Total Testosterone, Dyslipidemia and Anthropometric Parameters

Bakeer, E. M., Radwan, R. A., El-Mandoury, A. A.-A., Rahman, A. A. A. E., Gad, M. Z., & Maksoud, S. A. (2018) · Journal of Medical Biochemistry · doi:10.1515/jomb-2017-0068 · Cited by 31 · see citing works

Estrutura, metabolismo e funções fisiológicas da lipoproteína de alta densidade

Lima, É. S., & Couto, R. D. (2006) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442006000300005 · Cited by 31 · see citing works

Nuclear magnetic resonance–determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus

Ding, S.-Y., Tigno, X. T., & HANSEN, B. C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.015 · Cited by 30 · see citing works

C-Peptide Is a Sensitive Indicator for the Diagnosis of Metabolic Syndrome in Subjects from Central Mexico

González-Mejía, M. E., Porchia, L. M., Torres‐Rasgado, E., Ruiz‐Vivanco, G., Pulido‐Perez, P., Báez-Duarte, B. G., & Pérez-Fuentes, R. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0067 · Cited by 29 · see citing works

Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up

Medved, V., Kuzman, M. R., Jovanović, N., Grubišin, J., & Kuzman, T. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093927 · Cited by 29 · see citing works

The association between common genetic variation in the FTO gene and metabolic syndrome in Han Chinese.

Wang, T., Huang, Y., Xiao, X., Wang, D.-M., Diao, C., Zhang, F., Xu, L., Zhang, Y., Li, W.-H., Zhang, L.-L., et al. (2010) · PubMed · Cited by 28 · see citing works

Synthesis of a new insulin-mimetic anti-diabetic drug containing vitamin A and vanadium(IV) salt: Chemico-biological characterizations

Adam, A. M. A., Naglah, A. M., Al-Omar, M. A., & Refat, M. S. E.-D. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632017719601 · Cited by 26 · see citing works

Alterations in lipoprotein defense against oxidative stress in metabolic syndrome

Hansel, B., Kontush, A., Bonnefont‐Rousselot, D., Bruckert, É., & Chapman, M. J. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0026-8 · Cited by 26 · see citing works

Assessment of metabolic profile and ischemia-modified albumin level in patients with alopecia areata: A case–control study

Uysal, P. İ., Akdoğan, N., Allı, N., Öktem, A., Çandar, T., Topçuoğlu, C., & Turhan, T. (2019) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_238_18 · Cited by 25 · see citing works

The effects of ginger and its constituents in the prevention of metabolic syndrome: A review.

Salaramoli, S., Mehri, S., Yarmohammadi, F., Hashemy, S. I., & Hosseinzadeh, H. (2022) · PubMed Central · doi:10.22038/ijbms.2022.59627.13231 · Cited by 29 · see citing works

γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor

Kim, K., Goldberg, I. J., Graham, M. J., Sundaram, M., Bertaggia, E., Lee, S. X., Qiang, L., Haeusler, R. A., METZGER, D., Chambon, P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.010 · Cited by 26 · see citing works

Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome

Kim, J. J., Chae, S. J., Choi, Y. M., Hwang, K. R., Song, S. H., Yoon, S. H., Kim, S. M., Ku, S., Kim, S. H., Kim, J. G., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det057 · Cited by 24 · see citing works

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

Robinson, J. G., Ballantyne, C. M., Hsueh, W. A., Rosen, J., Lin, J., Shah, A. K., Lowe, R. S., Hanson, M. E., & Tershakovec, A. M. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.06.004 · Cited by 23 · see citing works

Differences in Expression of Cardiovascular Risk Factors among Type 2 Diabetes Mellitus Patients of Different Age

Kalofoutis, C., Piperi, C., Zisaki, A., Singh, J., HARRIS, F., Phoenix, D. A., ALAVERAS, A., & Kalofoutis, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.001 · Cited by 23 · see citing works

Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndrome

Lucero, D., Lopez, G. I., Gorzalczany, S. B., Duarte, M., Ballerga, E. G., Sorda, J. A., Schreier, L. E., & Zago, V. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.016 · Cited by 23 · see citing works

Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988--1991 to 2005--2008

Ford, E. S., Li, C., & Sniderman, A. D. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-26 · Cited by 20 · see citing works

Trichosanthes CucumerinaFruit Extenuates Dyslipidemia, Protein Oxidation, Lipid Peroxidation and DNA Fragmentation in the liver of high-fat diet-fed rats

Ajiboye, T. O., Akinpelu, S. A., Muritala, H. F., Ogunbode, S. M., Adeleye, A. O., Oladiji, A. T., & Oloyede, O. B. (2014) · Journal of Food Biochemistry · doi:10.1111/jfbc.12080 · Cited by 20 · see citing works

Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis

Pamir, N., McMillen, T. S., Li, Y., Lai, C.-M., Wong, H., & LeBoeuf, R. C. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.018 · Cited by 19 · see citing works

Supplementation with n-3, n-6, n-9 fatty acids in an insulin-resistance animal model: does it improve VLDL quality?

Lucero, D., Olano, C., Bursztyn, M., Morales, C., Stranges, A., Friedman, S., Macri, E. V., Schreier, L. E., & Zago, V. (2017) · Food & Function · doi:10.1039/c7fo00252a · Cited by 19 · see citing works

Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis

Navarro, H. G. (2007) · Frontiers in bioscience · doi:10.2741/2400 · Cited by 18 · see citing works

Phytotherapy for Polycystic Ovarian Syndrome: A review of the literature and evaluation of practitioners’ experiences

Rooney, S., & Pendry, B. A. (2014) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2014.05.001 · Cited by 17 · see citing works

Metabolic Syndrome in First Episode Schizophrenia, Based on the National Mental Health Registry of Schizophrenia (NMHR) in a General Hospital in Malaysia: A 10-Year Retrospective Cohort Study

Lee, A., Ng, C. G., Koh, O. H., Gill, J. S., & Aziz, S. A. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15050933 · Cited by 18 · see citing works

Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal.

Sigdel, M., Rajbhandari, N., Basnet, S., Nagila, A., Basnet, P., & Tamrakar, B. K. (2008) · PubMed · Cited by 16 · see citing works

The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date

Kolnikaj, T. S., Herman, R., Janež, A., & Jensterle, M. (2024) · Medicina · doi:10.3390/medicina60020244 · Cited by 17 · see citing works

Role of Glycation in Type 2 Diabetes Mellitus and Its Prevention through Nymphaea Species

Ishrat, N., Khan, H., Patel, O. P., Mahdi, A. A., Mujeeb, F., & Ahmad, S. (2021) · BioMed Research International · doi:10.1155/2021/7240046 · Cited by 17 · see citing works

A novel peroxisome proliferator–activated receptor α/γ dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys

Ding, S.-Y., Tigno, X. T., Braileanu, G., Ito, K., & HANSEN, B. C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.019 · Cited by 14 · see citing works

A review of the efficacy of rosuvastatin in patients with type 2 diabetes

Tuomilehto, J. O., Leiter, L. A., & Kallend, D. G. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00390.x · Cited by 14 · see citing works

Tattoo-induced psoriasis.

Orzan, O. A., Popa, L. G., Vexler, E. S., Olaru, I. D., Voiculescu, V. M., & Bumbăcea, R. S. (2014) · Europe PMC (PubMed Central) · Cited by 13 · see citing works

Anti-diabetic Effect of Material Fermented Using Rice Bran and Soybean as the Main Ingredient by Bacillus sp.

Lim, S. (2010) · Journal of the Korean Society for Applied Biological Chemistry · doi:10.3839/jksabc.2010.035 · Cited by 13 · see citing works

Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology

Sgarra, L., Addabbo, F., Potenza, M. A., & Montagnani, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00038.2012 · Cited by 13 · see citing works

Bezafibrate induces myotoxicity in human rhabdomyosarcoma cells via peroxisome proliferator-activated receptor α signaling

Zhao, Y., Okuyama, M., Hashimoto, H., Tagawa, Y., Jomori, T., & Yang, B. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.08.001 · Cited by 13 · see citing works

Leptin Receptor Gene Gln223Arg Polymorphism Is Not Associated with Hypertension: A Preliminary Population-Based Cross-Sectional Study

Pena, G. D. G., Guimarães, A. L. S., Veloso, R. R., Reis, T. C., Gomes, C. S., Neto, J. F. R., & Velásquez-Meléndez, G. (2014) · Cardiology Research and Practice · doi:10.1155/2014/879037 · Cited by 13 · see citing works

Impact of high-density lipoprotein cholesterol level in patients with variant angina pectoris

Sugano, Y., Anzai, T., Yagi, T., & Noma, S. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.053 · Cited by 12 · see citing works

Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats

El-Shazly, S. A., Ahmed, M. M., Ibrahim, Z. S., & Refat, M. S. E.-D. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015576036 · Cited by 11 · see citing works

Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]

Dutkowska, A., Konieczna, A., Breska-Kruszewska, J., Krzyczkowska-Sendrakowska, M., Kowalska, I., & Rachoń, D. (2019) · Endokrynologia Polska · doi:10.5603/ep.a2019.0006 · Cited by 11 · see citing works

CRP/HDL–C and Monocyte/HDL-C ratios as Predictors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

Đešević, M., Hasić, S., Lepara, O., Jahić, R., Kurtović, A., & Fajkić, A. (2023) · Acta Informatica Medica · doi:10.5455/aim.2023.31.254-259 · Cited by 10 · see citing works

A Randomized, Double-Blind Study of Fenofibric Acid Plus Rosuvastatin Compared With Rosuvastatin Alone in Stage 3 Chronic Kidney Disease

Weinstein, D. L., Williams, L. A., Carlson, D. M., Kelly, M. T., Burns, K. M., Setze, C. M., Lele, A., & Stolzenbach, J. C. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.06.013 · Cited by 12 · see citing works

Effect of Rhodiola rosea Rhizomes and Punica granatum Fruit Peel on the Metabolic Processes and Physiological Activity of Rats Fed with Excessive Fat Diet

Lieshchova, M. A., & Brygadyrenko, V. V. (2023) · Food Technology and Biotechnology · doi:10.17113/ftb.61.02.23.7913 · Cited by 10 · see citing works

Clinical use of thiazolidinediones: recommendations

Abrahamson, M. J. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.016 · Cited by 10 · see citing works

Effects of fluvastatin slow-release (xl 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes

Bevilacqua, M. T., Righini, V., Barrella, M., Vago, T., Chebat, E., & Dominguez, L. J. (2005) · Advances in Therapy · doi:10.1007/bf02849947 · Cited by 10 · see citing works

Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025

Rached, F. H., Miname, M. H., Rocha, V. Z., Zimerman, A., Cesena, F. Y., Sposito, A. C., Santos, R. D., Behr, P. E. B., Bianco, H. T., Alves, R. J., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250640 · Cited by 45 · see citing works

One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia

Ferdinand, K. C., Davidson, M. H., Kelly, M. T., & Setze, C. M. (2012) · American Journal of Cardiovascular Drugs · doi:10.2165/11597940-000000000-00000 · Cited by 9 · see citing works

Glucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes

Marrs, J. (2012) · Drugs & Aging · doi:10.2165/11599290-000000000-00000 · Cited by 9 · see citing works

Tratamiento de la hipertrigliceridemia: fibratos frente a ácidos grasos omega-3

Ros, E., & Laguna, J. C. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)74826-9 · Cited by 9 · see citing works

Elevated Membrane Cholesterol Disrupts Lysosomal Degradation to Induce β-Amyloid Accumulation

Takeuchi, S., Ueda, N., Suzuki, K., Shimozawa, N., Yasutomi, Y., & Kimura, N. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.011 · Cited by 9 · see citing works

Genistein effectiveness in improvement of glucose and lipid metabolism and homocysteine levels: A systematic review and meta-analysis

Braxas, H., Musazadeh, V., Zarezadeh, M., & Ostadrahimi, A. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105433 · Cited by 8 · see citing works

Obesidad, dislipemia y síndrome metabólico

Fernández, E. L., Rubio, B. O., Martínez, C. B., & Laclaustra, M. (2005) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(05)74117-0 · Cited by 8 · see citing works

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes

Hu, Z., Ren, L., Wang, C., Liu, B., & Song, G. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1830 · Cited by 8 · see citing works

Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome

Salehpour, S., Hosseini, S., Nazari, L., Saharkhiz, N., & Zademodarres, S. (2018) · JBRA · doi:10.5935/1518-0557.20180033 · Cited by 8 · see citing works

Obese First-Degree Relatives of Patients with Type 2 Diabetes with Elevated Triglyceride Levels Exhibit Increased β-Cell Function

Torres‐Rasgado, E., Porchia, L. M., Ruiz‐Vivanco, G., González-Mejía, M. E., Báez-Duarte, B. G., Pulido‐Perez, P., Rivera, A., Romero, J. R., & Pérez-Fuentes, R. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0095 · Cited by 7 · see citing works

The Metabolic Syndrome

Ruderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 7 · see citing works

Metabolic Syndrome and its Impact on Cardiovascular Diseases

Edla, N. K. J. P. S. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000142 · Cited by 6 · see citing works

Optimal management of lipids in diabetes and metabolic syndrome

Brown, W. V., Clark, L. T., Falko, J. M., Guyton, J. R., Rees, T., Schonfeld, G., & Lopes-Virella, M. F. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.08.444 · Cited by 16 · see citing works

Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia

Ayyobi, A. F., & Brunzell, J. D. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00613-1 · Cited by 95 · see citing works

Dyslipidaemia in the metabolic syndrome and type 2 diabetes: Pathogenesis, priorities, pharmacotherapies

Chan, D. C., & Watts, G. F. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.502529 · Cited by 69 · see citing works

Statin, Fibrat oder doch eine Kombination?

Geiß, H.-C., & Parhofer, K. G. (2006) · MMW - Fortschritte der Medizin · doi:10.1007/bf03364624

Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome

Cottrell, D. A., Marshall, B. J., & Falko, J. M. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200307000-00010 · Cited by 29 · see citing works